Welcome to GTx, a biopharmaceutical company dedicated to the discovery, development, and
commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions.
Our recognized scientific expertise is in the discovery and development of novel, selective small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. Click to learn more about our products in development. More...
GTx to Present Results on Enobosarm 9mg in Women with Metastatic Breast Cancer at 2014 San Antonio Breast Cancer Symposium Read More...
GTx Announces Closing of $43.4 Private Placement Read More...
GTx Announces Webcast of Corporate Presentation at the Stifel 2014 Healthcare Conference Read More...